Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

University of Toronto

$120,000.00

The Role of the Immunometabolism in Spondyloarthritis Drug Response Outcomes

FY 2025-26

Summary
Our proposal aims to improve treatment outcomes for patients with spondyloarthritis (SpA), a group of autoimmune diseases that cause joint inflammation, including axial spondyloarthritis (affecting the spine) and psoriatic arthritis (affecting skin and joints). Current biologic therapies help only about 60% of patients, leaving many without effective options. Understanding why treatments work for some but not others is critical. We focus on how the immune system's metabolism-the way immune cells use and process energy-affects disease activity and response to therapy. Immune cells change their metabolism during inflammation, which can affect their behavior and how they respond to medications. We will study differences in immune cells and metabolic profiles between patients who respond well to biologics and those who do not, and between the two types of SpA. Using blood samples from patients, we will analyze immune cell types, their activity, and the metabolites in their plasma. We will test how certain metabolites influence immune cell function in the lab. We will also explore whether blocking specific metabolic pathways can improve immune responses in patients who do not respond to treatment. The goal is to identify key immune and metabolic features that predict treatment success and to develop a predictive model. This could guide personalized medicine by helping doctors choose the best therapy for each patient. Ultimately, this research may lead to improved therapies and better quality of life for people with spondyloarthritis.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
559748
Name
Nguyen Phuong N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
The Role of the Immunometabolism in Spondyloarthritis Drug Response Outcomes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Ankylosing Spondylitis; Autoimmune Diseases; Immunometabolomics; Machine Learning; Personalized Medicine; Psoriatic Arthritis
Abstract
Our proposal aims to improve treatment outcomes for patients with spondyloarthritis (SpA), a group of autoimmune diseases that cause joint inflammation, including axial spondyloarthritis (affecting the spine) and psoriatic arthritis (affecting skin and joints). Current biologic therapies help only about 60% of patients, leaving many without effective options. Understanding why treatments work for some but not others is critical. We focus on how the immune system's metabolism-the way immune cells use and process energy-affects disease activity and response to therapy. Immune cells change their metabolism during inflammation, which can affect their behavior and how they respond to medications. We will study differences in immune cells and metabolic profiles between patients who respond well to biologics and those who do not, and between the two types of SpA. Using blood samples from patients, we will analyze immune cell types, their activity, and the metabolites in their plasma. We will test how certain metabolites influence immune cell function in the lab. We will also explore whether blocking specific metabolic pathways can improve immune responses in patients who do not respond to treatment. The goal is to identify key immune and metabolic features that predict treatment success and to develop a predictive model. This could guide personalized medicine by helping doctors choose the best therapy for each patient. Ultimately, this research may lead to improved therapies and better quality of life for people with spondyloarthritis.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Nguyen, Phuong N
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~